Abstract
This chapter describes the red blood cell (RBC) antigens that are most commonly encountered in the clinical practice of transfusion medicine. Blood group antigens are determined by either carbohydrate moieties linked to proteins or lipids or by amino acid sequences. Specificity of the carbohydrate-defined RBC antigens is determined by terminal sugars. Genes code for the production of enzymes that transfer these sugar molecules onto a protein or lipid. Specificity of the protein-defined RBC antigens is determined by amino acid sequences that are directly determined by genes. The proteins that carry blood group antigens are inserted into the RBC membrane in one of three ways: single-pass, multipass, or linked to phosphotidylinositol. Many factors influence the clinical significance of alloantibodies formed against RBC antigens. The prevalence of different RBC antibodies depends on both the prevalence of the corresponding RBC antigen in the population and the relative immunogenicity of the antigen. The clinical importance of a RBC antibody depends on both its prevalence in a population and whether it is likely to cause RBC destruction or hemolytic disease of the newborn. The type and degree of transfusion reactions and the degree of clinical hemolytic disease of the newborn (HDN) caused by antibodies to each blood group antigen system is reviewed in this chapter.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
